{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson\u2019s disease", "antiparkinsonian", "neuroprotection", "phenolic acids", "phytocompounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "38005310", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "27"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "14"}], "Language": ["eng"], "ELocationID": ["7588", "10.3390/molecules28227588"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "22", "PubDate": {"Year": "2023", "Month": "Nov", "Day": "14"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease.", "Abstract": {"AbstractText": ["Neurological ailments, including stroke, Alzheimer's disease (AD), epilepsy, Parkinson's disease (PD), and other related diseases, have affected around 1 billion people globally to date. PD stands second among the common neurodegenerative diseases caused as a result of dopaminergic neuron loss in the midbrain's substantia nigra regions. It affects cognitive and motor activities, resulting in tremors during rest, slow movement, and muscle stiffness. There are various traditional approaches for the management of PD, but they provide only symptomatic relief. Thus, a survey for finding new biomolecules or substances exhibiting the therapeutic potential to patients with PD is the main focus of present-day research. Medicinal plants, herbal formulations, and natural bioactive molecules have been gaining much more attention in recent years as synthetic molecules orchestrate a number of undesired effects. Several in vitro, in vivo, and in silico studies in the recent past have demonstrated the therapeutic potential of medicinal plants, herbal formulations, and plant-based bioactives. Among the plant-based bioactives, polyphenols, terpenes, and alkaloids are of particular interest due to their potent anti-inflammatory, antioxidant, and brain-health-promoting properties. Further, there are no concise, elaborated articles comprising updated mechanism-of-action-based reviews of the published literature on potent, recently investigated (2019-2023) medicinal plants, herbal formulations, and plant based-bioactive molecules, including polyphenols, terpenes, and alkaloids, as a method for the management of PD. Therefore, we designed the current review to provide an illustration of the efficacious role of various medicinal plants, herbal formulations, and bioactives (polyphenols, terpenes, and alkaloids) that can become potential therapeutics against PD with greater specificity, target approachability, bioavailability, and safety to the host. This information can be further utilized in the future to develop several value-added formulations and nutraceutical products to achieve the desired safety and efficacy for the management of PD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, School of Applied Sciences, REVA University, Bengaluru 560064, Karnataka, India."}], "LastName": "Kumari", "ForeName": "Nitu", "Initials": "N"}, {"Identifier": ["0000-0002-2445-8118"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, School of Applied Sciences, REVA University, Bengaluru 560064, Karnataka, India."}], "LastName": "Anand", "ForeName": "Santosh", "Initials": "S"}, {"Identifier": ["0000-0003-2389-0563"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Pharmaceutical Research, GLA University, Mathura 281406, Uttar Pradesh, India."}], "LastName": "Shah", "ForeName": "Kamal", "Initials": "K"}, {"Identifier": ["0000-0001-6748-5004"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Testing Laboratory Avam Anusandhan Kendra, Raipur 492010, Chhattisgarh, India."}], "LastName": "Chauhan", "ForeName": "Nagendra Singh", "Initials": "NS"}, {"Identifier": ["0000-0002-0192-1384"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, School of Pharmaceutical and Populations Health Informatics, DIT University, Dehradun 248009, Uttarakhand, India."}], "LastName": "Sethiya", "ForeName": "Neeraj K", "Initials": "NK"}, {"Identifier": ["0000-0002-1674-259X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Pharmacy, School of Pharmaceutical and Populations Health Informatics, DIT University, Dehradun 248009, Uttarakhand, India."}], "LastName": "Singhal", "ForeName": "Manmohan", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Terpenes"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Neurodegenerative Diseases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Terpenes"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bassett D.S., Gazzaniga M.S. Understanding complexity in the human brain. Trends Cogn. Sci. 2011;15:200\u2013209. doi: 10.1016/j.tics.2011.03.006.", "ArticleIdList": ["10.1016/j.tics.2011.03.006", "PMC3170818", "21497128"]}, {"Citation": "Colom R., Karama S., Jung R.E., Haier R.J. Human intelligence and brain networks. Dialogues Clin. Neurosci. 2010;12:489\u2013501. doi: 10.31887/DCNS.2010.12.4/rcolom.", "ArticleIdList": ["10.31887/DCNS.2010.12.4/rcolom", "PMC3181994", "21319494"]}, {"Citation": "Salim S. Oxidative Stress and the Central Nervous System. J. Pharmacol. Exp. Ther. 2017;360:201\u2013205. doi: 10.1124/jpet.116.237503.", "ArticleIdList": ["10.1124/jpet.116.237503", "PMC5193071", "27754930"]}, {"Citation": "Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;24:1583. doi: 10.3390/molecules24081583.", "ArticleIdList": ["10.3390/molecules24081583", "PMC6514564", "31013638"]}, {"Citation": "Vasic V., Barth K., Schmidt M.H.H. Neurodegeneration and Neuro-Regeneration-Alzheimer\u2019s Disease and Stem Cell Therapy. Int. J. Mol. Sci. 2019;20:4272. doi: 10.3390/ijms20174272.", "ArticleIdList": ["10.3390/ijms20174272", "PMC6747457", "31480448"]}, {"Citation": "Gao H., Hong J. Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol. 2008;29:357\u2013365. doi: 10.1016/j.it.2008.05.002.", "ArticleIdList": ["10.1016/j.it.2008.05.002", "PMC4794280", "18599350"]}, {"Citation": "Zia A., Pourbagher-Shahri A.M., Farkhondeh T. Saeed Samarghandian Molecular and cellular pathways contributing to brain aging. Behav. Brain Funct. 2021;17:6. doi: 10.1186/s12993-021-00179-9.", "ArticleIdList": ["10.1186/s12993-021-00179-9", "PMC8199306", "34118939"]}, {"Citation": "Rauf A., Badoni H., Abu-Izneid T., Olatunde A., Rahman M.M., Painuli S., Semwal P., Wilairatana P., Mubarak M.S. Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases. Molecules. 2022;27:3194. doi: 10.3390/molecules27103194.", "ArticleIdList": ["10.3390/molecules27103194", "PMC9146652", "35630670"]}, {"Citation": "Choonara Y.E., Pillay V., Toit L.C., Modi G., Naidoo D., Ndesendo V.M.K., Sibambo1 S.R. Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders. Int. J. Mol. Sci. 2009;10:2510\u20132557. doi: 10.3390/ijms10062510.", "ArticleIdList": ["10.3390/ijms10062510", "PMC2705504", "19582217"]}, {"Citation": "Reeve A., Simcox E., Turnbulla D. Ageing and Parkinson\u2019s disease: Why is advancing age the biggest risk factor? Ageing Res. Rev. 2014;14:19\u201330. doi: 10.1016/j.arr.2014.01.004.", "ArticleIdList": ["10.1016/j.arr.2014.01.004", "PMC3989046", "24503004"]}, {"Citation": "Pang S.Y.Y., Ho P.W.L., Liu H.F., Leung C., Li L., Chang E.E.S., Ramsden D.B., Ho S. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl. Neurodegener. 2019;8:23. doi: 10.1186/s40035-019-0165-9.", "ArticleIdList": ["10.1186/s40035-019-0165-9", "PMC6696688", "31428316"]}, {"Citation": "Kouli A., Torsney K.M., Kuan W.L.  Parkinson\u2019s Disease: Etiology, Neuropathology, and Pathogenesis. In: Stoker T.B., Greenland J.C., editors. Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects [Internet] Codon Publications; Brisbane, Australia: Dec 21, 2018.  [(accessed on 13 November 2023)].  Chapter 1. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK536722/"}, {"Citation": "Ma J., Gao J., Wang J., Xie A. Prion-Like Mechanisms in Parkinson\u2019s Disease. Front. Neurosci. 2019;13:552. doi: 10.3389/fnins.2019.00552.", "ArticleIdList": ["10.3389/fnins.2019.00552", "PMC6591488", "31275093"]}, {"Citation": "Calabresi P., Mechelli A., Natale G., Volpicelli-Daley L., Lazzaro G.D., Ghiglieri V. Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis. 2023;14:176. doi: 10.1038/s41419-023-05672-9.", "ArticleIdList": ["10.1038/s41419-023-05672-9", "PMC9977911", "36859484"]}, {"Citation": "Ni A., Ernst C. Evidence That Substantia Nigra Pars Compacta Dopaminergic Neurons Are Selectively Vulnerable to Oxidative Stress Because They Are Highly Metabolically Active. Front. Cell. Neurosci. 2022;16:826193. doi: 10.3389/fncel.2022.826193.", "ArticleIdList": ["10.3389/fncel.2022.826193", "PMC8931026", "35308118"]}, {"Citation": "Gonz\u00e1lez-Hern\u00e1ndez T., Rodr\u00edguez M. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat. J. Comp. Neurol. 2000;421:107\u2013135. doi: 10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F.", "ArticleIdList": ["10.1002/(SICI)1096-9861(20000522)421:1<107::AID-CNE7>3.0.CO;2-F", "10813775"]}, {"Citation": "Gr\u00f6ger A., Kolb R., Sch\u00e4fer R., Klose U. Dopamine Reduction in the Substantia Nigra of Parkinson\u2019s Disease Patients Confirmed by In Vivo Magnetic Resonance Spectroscopic Imaging. PLoS ONE. 2014;9:e84081. doi: 10.1371/journal.pone.0084081.", "ArticleIdList": ["10.1371/journal.pone.0084081", "PMC3885536", "24416192"]}, {"Citation": "Jankovic J., Aguilar L.G. Current approaches to the treatment of Parkinson\u2019s disease. Neuropsychiatr. Dis. Treat. 2008;4:743\u2013757. doi: 10.2147/NDT.S2006.", "ArticleIdList": ["10.2147/NDT.S2006", "PMC2536542", "19043519"]}, {"Citation": "Sarkar S., Raymick J., Imam S. Neuroprotective and Therapeutic Strategies against Parkinson\u2019s Disease: Recent Perspectives. Int. J. Mol. Sci. 2016;17:904. doi: 10.3390/ijms17060904.", "ArticleIdList": ["10.3390/ijms17060904", "PMC4926438", "27338353"]}, {"Citation": "Balakrishnan R., Azam S., Cho D., Su-Kim I., Choi D. Natural Phytochemicals as Novel Therapeutic Strategies to Prevent and Treat Parkinson\u2019s Disease: Current Knowledge and Future Perspectives. Oxid. Med. Cell. Longev. 2021;2021:6680935. doi: 10.1155/2021/6680935.", "ArticleIdList": ["10.1155/2021/6680935", "PMC8169248", "34122727"]}, {"Citation": "Mittal P., Dhankhar S., Chauhan S., Garg N., Bhattacharya T., Ali M., Chaudhary A.A., Rudayni H.A., Al-Zharani M., Ahmad W. A Review on Natural Antioxidants for Their Role in the Treatment of Parkinson\u2019s Disease. Pharmaceuticals. 2023;16:908. doi: 10.3390/ph16070908.", "ArticleIdList": ["10.3390/ph16070908", "PMC10385773", "37513820"]}, {"Citation": "Shahpiri Z., Bahramsoltani R., Farzaei M.H., Farzaei F., Rahimi R. Phytochemicals as future drugs for Parkinson\u2019s disease: A comprehensive review. Rev. Neurosci. 2016;27:651\u2013668. doi: 10.1515/revneuro-2016-0004.", "ArticleIdList": ["10.1515/revneuro-2016-0004", "27124673"]}, {"Citation": "Khan A., Jahan S., Imtiyaz Z., Alshahrani S., Makeen H.A., Alshehri B.M., Kumar A., Arafah A., Rehman M.U. Neuroprotection: Targeting Multiple Pathways by Naturally Occurring Phytochemicals. Biomedicines. 2020;8:284. doi: 10.3390/biomedicines8080284.", "ArticleIdList": ["10.3390/biomedicines8080284", "PMC7459826", "32806490"]}, {"Citation": "Varadi C. Clinical Features of Parkinson\u2019s Disease: The Evolution of Critical Symptoms. Biology. 2020;9:103. doi: 10.3390/biology9050103.", "ArticleIdList": ["10.3390/biology9050103", "PMC7285080", "32438686"]}, {"Citation": "Pyatha S., Kim H., Lee D., Kim K. Association between Heavy Metal Exposure and Parkinson\u2019s Disease: A Review of the Mechanisms Related to Oxidative Stress. Antioxidants. 2022;11:2467. doi: 10.3390/antiox11122467.", "ArticleIdList": ["10.3390/antiox11122467", "PMC9774122", "36552676"]}, {"Citation": "Zhou S., Zhou X., Jiang Z., Ma J., Li Y., Qian Z., Li H. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson\u2019s Disease. Neurochem. Res. 2023;48:942\u2013945. doi: 10.1007/s11064-022-03795-7.", "ArticleIdList": ["10.1007/s11064-022-03795-7", "36401052"]}, {"Citation": "Sharma S., Rabbani S.A., Agarwal T., Baboota S., Pottoo F.H., Kadian R. Nanotechnology Driven Approaches for the Management of Parkinson\u2019s Disease: Current Status and Future Perspectives. Curr. Drug Metab. 2021;22:287\u2013298. doi: 10.2174/1389200221666201124123405.", "ArticleIdList": ["10.2174/1389200221666201124123405", "33234098"]}, {"Citation": "Scott-Massey A., Boag M.K., Magnier A., Bispo D.P.C.F., Khoo T.K., Pountney D.L. Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson\u2019s Disease. Int. J. Mol. Sci. 2022;23:12928. doi: 10.3390/ijms232112928.", "ArticleIdList": ["10.3390/ijms232112928", "PMC9656009", "36361716"]}, {"Citation": "Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., Schrag A.E., Lang A.E. Parkinson disease. Nat. Rev. Dis. Primers. 2017;3:17013. doi: 10.1038/nrdp.2017.13.", "ArticleIdList": ["10.1038/nrdp.2017.13", "28332488"]}, {"Citation": "Mallet D., Dufourd T., Decourt M., Carcenac C., Boss\u00f9 P., Verlin L., Fernagut P., Benoit-Marand M., Spalletta G., Barbier E.L., et al. A metabolic biomarker predicts Parkinson\u2019s disease at the early stages in patients and animal models. J. Clin. Investig. 2022;132:e146400. doi: 10.1172/JCI146400.", "ArticleIdList": ["10.1172/JCI146400", "PMC8843749", "34914634"]}, {"Citation": "Chia S.J., Tan E.K., Chao Y.X. Historical Perspective: Models of Parkinson\u2019s Disease. Int. J. Mol. Sci. 2020;21:2464. doi: 10.3390/ijms21072464.", "ArticleIdList": ["10.3390/ijms21072464", "PMC7177377", "32252301"]}, {"Citation": "Pang M., Peng R., Wang Y., Zhu Y., Wang P., Moussian B., Su Y., Liu X., Ming D. Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson\u2019s disease. Biomed. Pharmacother. 2022;155:113718. doi: 10.1016/j.biopha.2022.113718.", "ArticleIdList": ["10.1016/j.biopha.2022.113718", "36152409"]}, {"Citation": "Rabiei Z., Solati K., Amini-Khoei H. Phytotherapy in treatment of Parkinson\u2019s disease: A review. Pharm. Biol. 2019;57:355\u2013362. doi: 10.1080/13880209.2019.1618344.", "ArticleIdList": ["10.1080/13880209.2019.1618344", "PMC6542178", "31141426"]}, {"Citation": "Corona J.C. Natural Compounds for the Management of Parkinson\u2019s Disease and Attention-Deficit/Hyperactivity Disorder. BioMed Res. Int. 2018;2018:4067597. doi: 10.1155/2018/4067597.", "ArticleIdList": ["10.1155/2018/4067597", "PMC6282143", "30596091"]}, {"Citation": "Cho B., Kim T., Huh Y., Lee J., Lee Y. Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson\u2019s Disease Models. Int. J. Mol. Sci. 2019;20:5208. doi: 10.3390/ijms20205208.", "ArticleIdList": ["10.3390/ijms20205208", "PMC6829248", "31640129"]}, {"Citation": "Khazdair M.R., Kianmehr M., Anaeigoudari A. Effects of Medicinal Plants and Flavonoids on Parkinson\u2019s Disease: A Review on Basic and Clinical Evidences. Adv. Pharm. Bull. 2021;11:224\u2013232. doi: 10.34172/apb.2021.026.", "ArticleIdList": ["10.34172/apb.2021.026", "PMC8046395", "33880344"]}, {"Citation": "Carrera I., Cacabelos R. Current Drugs and Potential Future Neuroprotective Compounds for Parkinson\u2019s Disease. Curr. Neuropharmacol. 2019;17:295\u2013306. doi: 10.2174/1570159X17666181127125704.", "ArticleIdList": ["10.2174/1570159X17666181127125704", "PMC6425078", "30479218"]}, {"Citation": "Yin R., Xue J., Tan Y., Fang C., Hu C., Yang Q., Mei X., Qi D. The Positive Role and Mechanism of Herbal Medicine in Parkinson\u2019s Disease. Oxid. Med. Cell. Longev. 2021;2021:9923331. doi: 10.1155/2021/9923331.", "ArticleIdList": ["10.1155/2021/9923331", "PMC8457986", "34567415"]}, {"Citation": "Sethiya N.K., Dube B., Mishra S.H. Herbs in Metal Health. Volume 1. LAP Lambert Academic Publishing; Saarbr\u00fccken, Germany: 2012. pp. 1\u201375."}, {"Citation": "Li J., He Y., Fu J., Wang Y., Fan X., Zhong T., Zhou H. Dietary supplementation of Acanthopanax senticosus extract alleviates motor deficits in MPTP-induced Parkinson\u2019s disease mice and its underlying mechanism. Front. Nutr. 2023;9:1121789. doi: 10.3389/fnut.2023.1121789.", "ArticleIdList": ["10.3389/fnut.2023.1121789", "PMC9971719", "36865944"]}, {"Citation": "Han C., Guo L., Yang Y., Li W., Sheng Y., Wang J., Guan Q., Zhang X. Study on antrodia camphorata polysaccharide in alleviating the neuroethology of PD mice by decreasing the expression of NLRP3 inflammasome. Phytother. Res. 2019;33:2288\u20132297. doi: 10.1002/ptr.6388.", "ArticleIdList": ["10.1002/ptr.6388", "31359520"]}, {"Citation": "Han C., Shen H., Yang Y., Sheng Y., Wang J., Li W., Zhou X., Guo L., Zhai L., Guan Q. Antrodia camphorata polysaccharide resists 6-OHDA-induced dopaminergic neuronal damage by inhibiting ROS-NLRP3 activation. Brain Behav. 2020;10:01824. doi: 10.1002/brb3.1824.", "ArticleIdList": ["10.1002/brb3.1824", "PMC7667329", "32902155"]}, {"Citation": "Wang C., Nguyen T., Yang X., Mellick G.D., Feng Y. Phytochemical investigation of Asarum sieboldii var. seoulense and the phenotypic profiles of its constituents against a Parkinson\u2019s Disease olfactory cell line. Bioorg. Med. Chem. Lett. 2023;92:129386. doi: 10.1016/j.bmcl.2023.129386.", "ArticleIdList": ["10.1016/j.bmcl.2023.129386", "37355024"]}, {"Citation": "Liu Y., Li H., Li Y., Yang M., Wang X., Peng Y. Velvet Antler Methanol Extracts Ameliorate Parkinson\u2019s Disease by Inhibiting Oxidative Stress and Neuroinflammation: From, C. elegans to Mice. Oxid. Med. Cell. Longev. 2021;2021:8864395. doi: 10.1155/2021/8864395.", "ArticleIdList": ["10.1155/2021/8864395", "PMC7811427", "33505591"]}, {"Citation": "Silva J., Martins A., Alves C., Pinteus S., Gaspar H., Alfonso A., Pedrosa R. Natural Approaches for Neurological Disorders-The Neuroprotective Potential of Codium tomentosum. Molecules. 2020;25:5478. doi: 10.3390/molecules25225478.", "ArticleIdList": ["10.3390/molecules25225478", "PMC7700523", "33238492"]}, {"Citation": "Omoruyi S.I., Ibrakaw A.S., Ekpo O.E., Boatwright J.S., Cupido C.N., Hussein A.A. Neuroprotective Activities of Crossyne flava Bulbs and Amaryllidaceae Alkaloids: Implications for Parkinson\u2019s Disease. Molecules. 2021;26:3990. doi: 10.3390/molecules26133990.", "ArticleIdList": ["10.3390/molecules26133990", "PMC8272225", "34208814"]}, {"Citation": "Ren Z., Wang C., Wang T., Ding H., Zhou M., Yang N., Liu Y., Chan P. Ganoderma lucidum extract ameliorates MPTP-induced parkinsonism and protects dopaminergic neurons from oxidative stress via regulating mitochondrial function, autophagy, and apoptosis. Acta Pharmacol. Sin. 2019;40:441\u2013450. doi: 10.1038/s41401-018-0077-8.", "ArticleIdList": ["10.1038/s41401-018-0077-8", "PMC6461997", "29991712"]}, {"Citation": "Arslan M.E., Y\u0131lmaz A. Neuroprotective effects of Geranium robertianum L. Aqueous extract on the cellular Parkinson\u2019s disease model. Eur. Rev. Med. Pharmacol. Sci. 2023;27:570\u2013579. doi: 10.26355/eurrev_202301_31058.", "ArticleIdList": ["10.26355/eurrev_202301_31058", "36734700"]}, {"Citation": "Siracusa R., Scuto M., Fusco R., Trovato A., Ontario M.L., Crea R., Paola R.D., Cuzzocrea S., Calabrese V. Anti-inflammatory and Anti-Oxidant Activity of Hidrox\u00ae in Rotenone-Induced Parkinson\u2019s Disease in Mice. Antioxidants. 2020;9:824. doi: 10.3390/antiox9090824.", "ArticleIdList": ["10.3390/antiox9090824", "PMC7576486", "32899274"]}, {"Citation": "Lin D., Zeng Y., Tang D., Cai Y. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson\u2019s Disease Based on Network Pharmacology. BioMed Res. Int. 2021;2021:4490081. doi: 10.1155/2021/4490081.", "ArticleIdList": ["10.1155/2021/4490081", "PMC8568527", "34746302"]}, {"Citation": "Kabra A., Baghel U.S., Hano C., Martins N., Khalid M., Sharma R. Neuroprotective potential of Myrica esulenta in Haloperidol induced Parkinson\u2019s disease. J. Ayurveda Integr. Med. 2020;11:448\u2013454. doi: 10.1016/j.jaim.2020.06.007.", "ArticleIdList": ["10.1016/j.jaim.2020.06.007", "PMC7772500", "32912644"]}, {"Citation": "Ly H.T., Nguyen T.T.H., Le V.M., Lam B.T., Mai T.T.T., Dang T.P.T. Therapeutic Potential of Polyscias fruticosa (L.) Harms Leaf Extract for Parkinson\u2019s Disease Treatment by Drosophila melanogaster Model. Oxid. Med. Cell. Longev. 2022;2022:5262677. doi: 10.1155/2022/5262677.", "ArticleIdList": ["10.1155/2022/5262677", "PMC9135533", "35633880"]}, {"Citation": "Nghi N.B.T., Uyen T.T., Anh H.M., Linh D.M., Thao D.T.P. Rumdul (Sphaerocoryne affinis) Antioxidant Activity and Its Potential for Parkinson\u2019s Disease Treatment. Oxid. Med. Cell. Longev. 2022;2022:8918966. doi: 10.1155/2022/8918966.", "ArticleIdList": ["10.1155/2022/8918966", "PMC8956402", "35340209"]}, {"Citation": "Sanad S.M., Farouk R., Nassar S.E., Alshahrani M.Y., Suliman M., Ahmed A.E., Elesawi I.E. The neuroprotective effect of quercetin nanoparticles in the therapy of neuronal damage stimulated by acrolein. Saudi J. Biol. Sci. 2023;30:103792. doi: 10.1016/j.sjbs.2023.103792.", "ArticleIdList": ["10.1016/j.sjbs.2023.103792", "PMC10498005", "37711970"]}, {"Citation": "Yarim G.F., Kazak F., Yarim M., Sozmen M., Genc B., Ertekin A., Gokceoglu A. Apigenin alleviates neuroinflammation in a mouse model of Parkinson\u2019s disease. Int. J. Neurosci. 2022;26:1\u201310. doi: 10.1080/00207454.2022.2089136.", "ArticleIdList": ["10.1080/00207454.2022.2089136", "35698811"]}, {"Citation": "Sharma N., Soni R., Sharma M., Chatterjee S., Parihar N., Mukarram M., Kale R., Sayyed A.A., Behera S.K., Khairnar A. Chlorogenic Acid: A Polyphenol from Coffee Rendered Neuroprotection Against Rotenone-Induced Parkinson\u2019s Disease by GLP-1 Secretion. Mol. Neurobiol. 2022;59:6834\u20136856. doi: 10.1007/s12035-022-03005-z.", "ArticleIdList": ["10.1007/s12035-022-03005-z", "36048341"]}, {"Citation": "Gao X., Zhang B., Zheng Y., Liu X., Rostyslav P., Finiuk N., Sik A., Stoika R., Liu K., Jin M. Neuroprotective effect of chlorogenic acid on Parkinson\u2019s disease like symptoms through boosting the autophagy in zebrafish. Eur. J. Pharmacol. 2023;956:175950. doi: 10.1016/j.ejphar.2023.175950.", "ArticleIdList": ["10.1016/j.ejphar.2023.175950", "37544423"]}, {"Citation": "Brunetti G., Rosa G.D., Scuto M., Leri M., Stefani M., Schmitz-Linneweber C., Calabrese V., Saul N. Healthspan Maintenance and Prevention of Parkinson\u2019s-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans. Int. J. Mol. Sci. 2020;21:2588. doi: 10.3390/ijms21072588.", "ArticleIdList": ["10.3390/ijms21072588", "PMC7178172", "32276415"]}, {"Citation": "Gallardo-Fern\u00e1ndez M., Hornedo-Ortega R., Alonso-Bellido I.M., Rodr\u00edguez-G\u00f3mez J.A., Troncoso A.M., Garc\u00eda-Parrilla M.C., Venero J.L., Espinosa-Oliva A.M., de Pablos R.M. Hydroxytyrosol Decreases LPS- and \u03b1-Synuclein-Induced Microglial Activation in Vitro. Antioxidants. 2020;9:36. doi: 10.3390/antiox9010036.", "ArticleIdList": ["10.3390/antiox9010036", "PMC7022576", "31906130"]}, {"Citation": "Pathania A., Kumar R., Sandhir R. Hydroxytyrosol as anti-parkinsonian molecule: Assessment using in-silico and MPTP-induced Parkinson\u2019s disease model. Biomed. Pharmacother. 2021;139:111525. doi: 10.1016/j.biopha.2021.111525.", "ArticleIdList": ["10.1016/j.biopha.2021.111525", "33882412"]}, {"Citation": "Perez-Barron G., Montes S., Aguirre-Vidal Y., Santiago M., Gallardo E., Espartero J.L., R\u00edos C., Monroy-Noyola A. Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP+ Model of Parkinson\u2019s Disease. Neurochem. Res. 2021;46:2923\u20132935. doi: 10.1007/s11064-021-03379-x.", "ArticleIdList": ["10.1007/s11064-021-03379-x", "34260002"]}, {"Citation": "Mursaleen L., Noble B., Somavarapu S., Zariwala M.G. Micellar Nanocarriers of Hydroxytyrosol Are Protective against Parkinson\u2019s Related Oxidative Stress in an in Vitro hCMEC/D3-SH-SY5Y Co-Culture System. Antioxidants. 2021;10:887. doi: 10.3390/antiox10060887.", "ArticleIdList": ["10.3390/antiox10060887", "PMC8226543", "34073115"]}, {"Citation": "Ba Q., Cui C., Wen L., Feng S., Zhou J., Yang K. Schisandrin B shows neuroprotective effect in 6-OHDA-induced Parkinson\u2019s disease via inhibiting the negative modulation of miR-34a on Nrf2 pathway. Biomed. Pharmacother. 2015;75:165\u2013172. doi: 10.1016/j.biopha.2015.07.034.", "ArticleIdList": ["10.1016/j.biopha.2015.07.034", "26282218"]}, {"Citation": "Vijayakumaran S., Nakamura Y., Henley J.M., Pountney D.L. Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates. Mol. Cell. Neurosci. 2019;101:103416. doi: 10.1016/j.mcn.2019.103416.", "ArticleIdList": ["10.1016/j.mcn.2019.103416", "31654699"]}, {"Citation": "Zou Z.C., Fu J.J., Dang Y.Y., Zhang Q., Wang X.F., Chen H.B., Jia X.J., Lee S.M., Li C.W. Pinocembrin-7-Methylether Protects SH-SY5Y Cells Against 6-Hydroxydopamine-Induced Neurotoxicity via Modulating Nrf2 Induction Through AKT and ERK Pathways. Neurotox. Res. 2021;39:1323\u20131337. doi: 10.1007/s12640-021-00376-4.", "ArticleIdList": ["10.1007/s12640-021-00376-4", "33999357"]}, {"Citation": "Mishra A., Mishra P.S., Bandopadhyay R., Khurana N., Angelopoulou E., Paudel Y.N., Piperi C. Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders. Molecules. 2021;26:6456. doi: 10.3390/molecules26216456.", "ArticleIdList": ["10.3390/molecules26216456", "PMC8588021", "34770864"]}, {"Citation": "Yan X., Liu D., Zhang X., Liu D., Xu S., Chen G., Huang B., Ren W., Wang W., Fu S., et al. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-\u03baB Signaling Pathway. Int. J. Mol. Sci. 2017;18:389. doi: 10.3390/ijms18020389.", "ArticleIdList": ["10.3390/ijms18020389", "PMC5343924", "28208679"]}, {"Citation": "Long T., Wu Q., Wei J., Tang Y., He Y., He C., Chen X., Yu L., Yu C., Law B.Y., et al. Ferulic Acid Exerts Neuroprotective Effects via Autophagy Induction in C. elegans and Cellular Models of Parkinson\u2019s Disease. Oxid. Med. Cell. Longev. 2022;2022:3723567. doi: 10.1155/2022/3723567.", "ArticleIdList": ["10.1155/2022/3723567", "PMC8888115", "35242276"]}, {"Citation": "Varshney M., Kumar B., Rana V.S., Sethiya N.K. An Overview on Therapeutic and Medicinal Potential of Poly-hydroxy Flavone viz. Heptamethoxyflavone, Kaempferitrin, Vitexin and Amentoflavone for Management of Alzheimer\u2019s and Parkinson\u2019s Diseases: A critical analysis on mechanistic insight. Crit. Rev. Food Sci. Nutr. 2023;63:2749\u20132772. doi: 10.1080/10408398.2021.1980761.", "ArticleIdList": ["10.1080/10408398.2021.1980761", "34590507"]}, {"Citation": "Walia V., Chaudhary S.K., Sethiya N.K. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders. Neurochem. Int. 2021;143:104939. doi: 10.1016/j.neuint.2020.104939.", "ArticleIdList": ["10.1016/j.neuint.2020.104939", "33346032"]}, {"Citation": "Sethiya N.K., Ghiloria N., Srivastav A., Bisht D., Chaudhary S.K., Walia V., Alam M.S. Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders. CNS Neurol. Disord. Drug Targets. 2023 doi: 10.2174/1871527322666230718105358. online ahead of print .", "ArticleIdList": ["10.2174/1871527322666230718105358", "37461364"]}, {"Citation": "Chen D., Zhang X., Sun J., Cong Q., Chen W., Ahsan H.M., Gao J., Qian J. Asiatic Acid Protects Dopaminergic Neurons from Neuroinflammation by Suppressing Mitochondrial ROS Production. Biomol. Ther. 2019;27:442\u2013449. doi: 10.4062/biomolther.2018.188.", "ArticleIdList": ["10.4062/biomolther.2018.188", "PMC6720531", "30971058"]}, {"Citation": "He Z., Huan P., Wang L., He J. Paeoniflorin ameliorates cognitive impairment in Parkinson\u2019s disease via JNK/p53 signaling. Metab. Brain Dis. 2022;37:1057\u20131070. doi: 10.1007/s11011-022-00937-2.", "ArticleIdList": ["10.1007/s11011-022-00937-2", "PMC9042992", "35230626"]}, {"Citation": "Xu C., Qu R., Zhang J., Li L., Ma S. Neuroprotective effects of Madecassoside in early stage of Parkinson\u2019s disease induced by MPTP in rats. Fitoterapia. 2013;90:112\u2013118. doi: 10.1016/j.fitote.2013.07.009.", "ArticleIdList": ["10.1016/j.fitote.2013.07.009", "23876367"]}, {"Citation": "Xu Y., Cui C., Sun M., Zhu Y., Chu M., Shi Y., Lin S.L., Yang X., Shen Y. Neuroprotective Effects of Loganin on MPTP-Induced Parkinson\u2019s Disease Mice: Neurochemistry, Glial Reaction and Autophagy Studies. J. Cell. Biochem. 2017;118:3495\u20133510. doi: 10.1002/jcb.26010.", "ArticleIdList": ["10.1002/jcb.26010", "28338241"]}, {"Citation": "Ahmed S., Panda S.R., Kwatra M., Sahu B.D., Naidu V. Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson\u2019s Disease. ACS Chem. Neurosci. 2022;13:53\u201368. doi: 10.1021/acschemneuro.1c00550.", "ArticleIdList": ["10.1021/acschemneuro.1c00550", "34904823"]}, {"Citation": "Lee T., Yang W., Cha D.S., Han Y.T. Synthesis of a natural quinoline alkaloid isolated from the deep-sea-derived fungus and its potential as a therapeutic for Parkinson\u2019s disease. J. Asian Nat. Prod. Res. 2023;25:446\u2013455. doi: 10.1080/10286020.2022.2104259.", "ArticleIdList": ["10.1080/10286020.2022.2104259", "35980025"]}, {"Citation": "Li Y.J., Li J., Xie L., Zhou J.Y., Li Q.X., Yang R.Y., Liu Y.P., Fu Y.H. Monoterpenoids indole alkaloids with potential neuroprotective activities from the stems and leaves of Melodinus cochinchinensis. Nat. Prod. Res. 2022;36:5181\u20135188. doi: 10.1080/14786419.2021.1922406.", "ArticleIdList": ["10.1080/14786419.2021.1922406", "33960216"]}, {"Citation": "Wang Y., Tong Q., Ma S.R., Zhao Z., Pan L., Cong L., Han P., Peng R., Yu H., Lin Y., et al. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson\u2019s disease by regulating gut microbiota. Signal Transduct. Target. Ther. 2021;6:77. doi: 10.1038/s41392-020-00456-5.", "ArticleIdList": ["10.1038/s41392-020-00456-5", "PMC7902645", "33623004"]}, {"Citation": "Schepici G., Silvestro S., Bramanti P., Mazzon E. Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson\u2019s Disease. Int. J. Mol. Sci. 2020;21:4766. doi: 10.3390/ijms21134766.", "ArticleIdList": ["10.3390/ijms21134766", "PMC7369844", "32635541"]}, {"Citation": "Jayaraj R.L., Beiram R., Azimullah S., Meeran M.F.N., Ojha S.K., Adem A., Jalal F.Y. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson\u2019s Disease. Molecules. 2019;24:2182. doi: 10.3390/molecules24112182.", "ArticleIdList": ["10.3390/molecules24112182", "PMC6600474", "31185705"]}, {"Citation": "Singh A.K., Singla R.K., Pandey A.K. Chlorogenic Acid: A Dietary Phenolic Acid with Promising Pharmacotherapeutic Potential. Curr. Med. Chem. 2023;30:3905\u20133926. doi: 10.2174/0929867329666220816154634.", "ArticleIdList": ["10.2174/0929867329666220816154634", "35975861"]}, {"Citation": "Uddin M.S., Al Mamun A., Kabir M.T., Ahmad J., Jeandet P., Sarwar M.S., Ashraf G.M., Aleya L. Neuroprotective role of polyphenols against oxidative stress-mediated neurodegeneration. Eur. J. Pharmacol. 2020;886:173412. doi: 10.1016/j.ejphar.2020.173412.", "ArticleIdList": ["10.1016/j.ejphar.2020.173412", "32771668"]}, {"Citation": "Arias-S\u00e1nchez R.A., Torner L., Fenton Navarro B. Polyphenols and Neurodegenerative Diseases: Potential Effects and Mechanisms of Neuroprotection. Molecules. 2023;28:5415. doi: 10.3390/molecules28145415.", "ArticleIdList": ["10.3390/molecules28145415", "PMC10385962", "37513286"]}, {"Citation": "Efimova S.S., Ostroumova O.S. Modulation of the Dipole Potential of Model Lipid Membranes with Phytochemicals: Molecular Mechanisms, Structure-Activity Relationships, and Implications in Reconstituted Ion Channels. Membranes. 2023;13:453. doi: 10.3390/membranes13040453.", "ArticleIdList": ["10.3390/membranes13040453", "PMC10141572", "37103880"]}, {"Citation": "Anand S., Sowbhagya R., Ansari M.A., Alzohairy M.A., Alomary M.N., Almalik A.I., Ahmad W., Tripathi T., Elderdery A.Y. Polyphenols and Their Nanoformulations: Protective Effects against Human Diseases. Life. 2022;12:1639. doi: 10.3390/life12101639.", "ArticleIdList": ["10.3390/life12101639", "PMC9604961", "36295074"]}, {"Citation": "Liu S., Cheng L., Liu Y., Zhan S., Wu Z., Zhang X. Relationship between Dietary Polyphenols and Gut Microbiota: New Clues to Improve Cognitive Disorders, Mood Disorders and Circadian Rhythms. Foods. 2023;12:1309. doi: 10.3390/foods12061309.", "ArticleIdList": ["10.3390/foods12061309", "PMC10048542", "36981235"]}, {"Citation": "Platzer M., Kiese S., Tybussek T., Herfellner T., Schneider F., Schweiggert-Weisz U., Eisner P. Radical Scavenging Mechanisms of Phenolic Compounds: A Quantitative Structure-Property Relationship (QSPR) Study. Front. Nutr. 2022;9:882458. doi: 10.3389/fnut.2022.882458.", "ArticleIdList": ["10.3389/fnut.2022.882458", "PMC9013829", "35445057"]}, {"Citation": "Lopez-Corona A.V., Valencia-Espinosa I., Gonz\u00e1lez-S\u00e1nchez F.A., S\u00e1nchez-L\u00f3pez A.L., Garcia-Amezquita L.E., Garcia-Varela R. Antioxidant, Anti-Inflammatory and Cytotoxic Activity of Phenolic Compound Family Extracted from Raspberries (Rubus idaeus): A General Review. Antioxidants. 2022;11:1192. doi: 10.3390/antiox11061192.", "ArticleIdList": ["10.3390/antiox11061192", "PMC9230908", "35740089"]}, {"Citation": "Zhang Z., Hamada H., Gerk P.M. Selectivity of Dietary Phenolics for Inhibition of Human Monoamine Oxidases A and B. BioMed Res. Int. 2019;2019:8361858. doi: 10.1155/2019/8361858.", "ArticleIdList": ["10.1155/2019/8361858", "PMC6364133", "30809547"]}, {"Citation": "Shih J.C., Chen K., Ridd M.J. MONOAMINE OXIDASE: From Genes to Behavior. Annu. Rev. Neurosci. 1999;22:197\u2013217. doi: 10.1146/annurev.neuro.22.1.197.", "ArticleIdList": ["10.1146/annurev.neuro.22.1.197", "PMC2844879", "10202537"]}, {"Citation": "Carecho R., Carregosa D., Ratilal B.O., Figueira I., \u00c1vila-G\u00e1lvez M.A., Santos C.N., Loncarevic-Vasiljkovic N. Dietary (Poly)phenols in Traumatic Brain Injury. Int. J. Mol. Sci. 2023;24:8908. doi: 10.3390/ijms24108908.", "ArticleIdList": ["10.3390/ijms24108908", "PMC10219504", "37240254"]}, {"Citation": "Grabska-Koby\u0142ecka I., Szpakowski P., Kr\u00f3l A., Ksi\u0105\u017cek-Winiarek D., Koby\u0142ecki A., G\u0142\u0105bi\u0144ski A., Nowak D. Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development. Nutrients. 2023;15:3454. doi: 10.3390/nu15153454.", "ArticleIdList": ["10.3390/nu15153454", "PMC10420887", "37571391"]}, {"Citation": "Vauzour D. Dietary Polyphenols as Modulators of Brain Functions: Biological Actions and Molecular Mechanisms Underpinning Their Beneficial Effects. Oxid. Med. Cell. Longev. 2012;2012:914273. doi: 10.1155/2012/914273.", "ArticleIdList": ["10.1155/2012/914273", "PMC3372091", "22701758"]}, {"Citation": "Shahidi F., Ambigaipalan P. Phenolics and polyphenolics in foods, beverages and spices: Antioxidant activity and health effects\u2014A review. J. Funct. Foods. 2015;18:820\u2013897. doi: 10.1016/j.jff.2015.06.018.", "ArticleIdList": ["10.1016/j.jff.2015.06.018"]}, {"Citation": "Li M., Qian M., Jiang Q., Tan B., Yin Y., Han X. Evidence of Flavonoids on Disease Prevention. Antioxidants. 2023;12:527. doi: 10.3390/antiox12020527.", "ArticleIdList": ["10.3390/antiox12020527", "PMC9952065", "36830086"]}, {"Citation": "Sun W., Shahrajabian M.H. Therapeutic Potential of Phenolic Compounds in Medicinal Plants\u2014Natural Health Products for Human Health. Molecules. 2023;28:1845. doi: 10.3390/molecules28041845.", "ArticleIdList": ["10.3390/molecules28041845", "PMC9960276", "36838831"]}, {"Citation": "Yan L., Guo M., Zhang Y., Yu L., Wu J., Tang Y., Ai W., Zhu F., Law B.Y., Chen Q., et al. Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities. Oxid. Med. Cell. Longev. 2022;2022:5288698. doi: 10.1155/2022/5288698.", "ArticleIdList": ["10.1155/2022/5288698", "PMC8885204", "35237381"]}, {"Citation": "Chen S., Wang X., Cheng Y., Gao H., Chen X. A Review of Classification, Biosynthesis, Biological Activities and Potential Applications of Flavonoids. Molecules. 2023;28:4982. doi: 10.3390/molecules28134982.", "ArticleIdList": ["10.3390/molecules28134982", "PMC10343696", "37446644"]}, {"Citation": "Bellavite P. Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants. 2023;12:280. doi: 10.3390/antiox12020280.", "ArticleIdList": ["10.3390/antiox12020280", "PMC9951959", "36829840"]}, {"Citation": "Spiegel M., Andruni\u00f3w T., Sroka Z. Flavones\u2019 and Flavonols\u2019 Antiradical Structure\u2013Activity Relationship\u2014A Quantum Chemical Study. Antioxidants. 2020;9:461. doi: 10.3390/antiox9060461.", "ArticleIdList": ["10.3390/antiox9060461", "PMC7346117", "32471289"]}, {"Citation": "Kumar S., Pandey A.K. Chemistry and Biological Activities of Flavonoids: An Overview. Sci. World J. 2013;2013:162750. doi: 10.1155/2013/162750.", "ArticleIdList": ["10.1155/2013/162750", "PMC3891543", "24470791"]}, {"Citation": "Devi S., Kumar V., Singh S.K., Dubey A.K., Kim J.J. Flavonoids: Potential Candidates for the Treatment of Neurodegenerative Disorders. Biomedicines. 2021;9:99. doi: 10.3390/biomedicines9020099.", "ArticleIdList": ["10.3390/biomedicines9020099", "PMC7909525", "33498503"]}, {"Citation": "Singh S., Gupta P., Meena A., Luqman S. Acacetin, a flavone with diverse therapeutic potential in cancer, inflammation, infections and other metabolic disorders. Food Chem. Toxicol. 2020;145:111708. doi: 10.1016/j.fct.2020.111708.", "ArticleIdList": ["10.1016/j.fct.2020.111708", "32866514"]}, {"Citation": "Kim H.G., Ju M.S., Ha S.K., Lee H., Lee H., Kim S.Y., Oh M.S. Acacetin protects dopaminergic cells against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuroinflammation in vitro and in vivo. Biol. Pharm. Bull. 2012;35:1287\u20131294. doi: 10.1248/bpb.b12-00127.", "ArticleIdList": ["10.1248/bpb.b12-00127", "22863927"]}, {"Citation": "Kim S.M., Park Y.J., Shin M., Kim H., Kim M.J., Lee S.H., Yun S.P., Kwon S. Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson\u2019s disease model. Bioorg. Med. Chem. Lett. 2017;27:5207\u20135212. doi: 10.1016/j.bmcl.2017.10.048.", "ArticleIdList": ["10.1016/j.bmcl.2017.10.048", "29089232"]}, {"Citation": "Zhao Q., Chen X., Martin C. Scutellaria baicalensis, the golden herb from the garden of Chinese medicinal plants. Sci. Bull. 2016;61:1391\u20131398. doi: 10.1007/s11434-016-1136-5.", "ArticleIdList": ["10.1007/s11434-016-1136-5", "PMC5031759", "27730005"]}, {"Citation": "Jadhav R., Kulkarni Y.A. Effects of baicalein with memantine on aluminium chloride-induced neurotoxicity in Wistar rats. Front. Pharmacol. 2023;14:1034620. doi: 10.3389/fphar.2023.1034620.", "ArticleIdList": ["10.3389/fphar.2023.1034620", "PMC9992210", "36909151"]}, {"Citation": "Li Y., Zhao J., H\u00f6lscher C. Therapeutic Potential of Baicalein in Alzheimer\u2019s Disease and Parkinson\u2019s Disease. CNS Drugs. 2017;31:639\u2013652. doi: 10.1007/s40263-017-0451-y.", "ArticleIdList": ["10.1007/s40263-017-0451-y", "28634902"]}, {"Citation": "Wang Y., Wei N., Li X. Preclinical Evidence and Possible Mechanisms of Baicalein for Rats and Mice with Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis. Front. Aging Neurosci. 2020;12:277. doi: 10.3389/fnagi.2020.00277.", "ArticleIdList": ["10.3389/fnagi.2020.00277", "PMC7546397", "33101006"]}, {"Citation": "Chen M., Peng L., Gong P., Zheng X., Sun T., Zhang X., Huo J. Baicalein Induces Mitochondrial Autophagy to Prevent Parkinson\u2019s Disease in Rats via miR-30b and the SIRT1/AMPK/mTOR Pathway. Front. Neurol. 2021;12:646817. doi: 10.3389/fneur.2021.646817.", "ArticleIdList": ["10.3389/fneur.2021.646817", "PMC8883053", "35237220"]}, {"Citation": "Wang Y., Wu S., Li Q., Lang W., Li W., Jiang X., Wan Z., Chen J., Wang H. Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson\u2019s disease. Front. Pharmacol. 2022;13:977521. doi: 10.3389/fphar.2022.977521.", "ArticleIdList": ["10.3389/fphar.2022.977521", "PMC9511047", "36172194"]}, {"Citation": "Sergi C.M. Epigallocatechin gallate for Parkinson\u2019s disease. Clin. Exp. Pharmacol. Physiol. 2022;49:1029\u20131041. doi: 10.1111/1440-1681.13691.", "ArticleIdList": ["10.1111/1440-1681.13691", "35748799"]}, {"Citation": "Xu Y., Xie M., Xue J., Xiang L., Li Y., Xiao J., Xiao G., Wang H. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson\u2019s disease. FASEB J. 2020;34:5931\u20135950. doi: 10.1096/fj.201903125RR.", "ArticleIdList": ["10.1096/fj.201903125RR", "32157731"]}, {"Citation": "Caruana M., Vassallo N. Tea Polyphenols in Parkinson\u2019s Disease. Adv. Exp. Med. Biol. 2015;863:117\u2013137. doi: 10.1007/978-3-319-18365-7_6.", "ArticleIdList": ["10.1007/978-3-319-18365-7_6", "26092629"]}, {"Citation": "Anandhan A., Tamilselvam K., Radhiga T., Rao S., Essa M.M.E., Manivasagam T. Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson\u2019s disease. Brain Res. 2012;1433:104\u2013113. doi: 10.1016/j.brainres.2011.11.021.", "ArticleIdList": ["10.1016/j.brainres.2011.11.021", "22138428"]}, {"Citation": "Grelle G., Otto A., Lorenz M., Frank R.F., Wanker E.E., Bieschke J. Black tea theaflavins inhibit formation of toxic amyloid-\u03b2 and \u03b1-synuclein fibrils. Biochemistry. 2011;50:10624\u201310636. doi: 10.1021/bi2012383.", "ArticleIdList": ["10.1021/bi2012383", "22054421"]}, {"Citation": "Park B.C., Lee Y.S., Park H., Kwak M., Yoo B.K., Kim J.Y., Kim J. Protective effects of fustin, a flavonoid from Rhus verniciflua Stokes, on 6-hydroxydopamine-induced neuronal cell death. Exp. Mol. Med. 2007;39:316\u2013326. doi: 10.1038/emm.2007.35.", "ArticleIdList": ["10.1038/emm.2007.35", "17603285"]}, {"Citation": "Hajialyani M., Farzaei M.H., Echeverr\u00eda J., Nabavi S.M., Uriarte E., Sobarzo-S\u00e1nchez E. Hesperidin as a Neuroprotective Agent: A Review of Animal and Clinical Evidence. Molecules. 2019;24:648. doi: 10.3390/molecules24030648.", "ArticleIdList": ["10.3390/molecules24030648", "PMC6384806", "30759833"]}, {"Citation": "Atoki A.V., Aja P.M., Shinkafi T.S., Ondari E.N., Awuchi C.G. Hesperidin plays beneficial roles in disorders associated with the central nervous system: A review. Int. J. Food Prop. 2023;26:1867\u20131884. doi: 10.1080/10942912.2023.2236327.", "ArticleIdList": ["10.1080/10942912.2023.2236327"]}, {"Citation": "Tamilselvam K., Braidy N., Manivasagam T., Essa M.M., Prasad N.R., Karthikeyan S., Thenmozhi A.J., Selvaraju S., Guillemin G.J. Neuroprotective Effects of Hesperidin, a Plant Flavanone, on Rotenone-Induced Oxidative Stress and Apoptosis in a Cellular Model for Parkinson\u2019s Disease. Oxid. Med. Cell. Longev. 2013;2013:102741. doi: 10.1155/2013/102741.", "ArticleIdList": ["10.1155/2013/102741", "PMC3800605", "24205431"]}, {"Citation": "Antunes M.S., Goes A.T.R., Boeira S.P., Prigol M., Jesse C.R. Protective effect of hesperidin in a model of Parkinson\u2019s disease induced by 6-hydroxydopamine in aged mice. Nutrition. 2014;30:1415\u20131422. doi: 10.1016/j.nut.2014.03.024.", "ArticleIdList": ["10.1016/j.nut.2014.03.024", "25280422"]}, {"Citation": "Li P., Feng D., Yang D., Li X., Sun J., Wang G., Tian L., Jiang X., Bai W. Protective effects of anthocyanins on neurodegenerative diseases. Trends Food Sci. Technol. 2021;117:205\u2013217. doi: 10.1016/j.tifs.2021.05.005.", "ArticleIdList": ["10.1016/j.tifs.2021.05.005"]}, {"Citation": "Winter A.N., Bickford P.C. Anthocyanins and Their Metabolites as Therapeutic Agents for Neurodegenerative Disease. Antioxidants. 2019;8:333. doi: 10.3390/antiox8090333.", "ArticleIdList": ["10.3390/antiox8090333", "PMC6770078", "31443476"]}, {"Citation": "Strathearn K.E., Yousef G.G., Grace M.H., Roy S.L., Tambe M.A., Ferruzzi M.G., Wu Q., Simon J.E., Lila M.A., Rochet J. Neuroprotective effects of anthocyanin- and proanthocyanidin-rich extracts in cellular models of Parkinsons disease. Brain Res. 2014;1555:60\u201377. doi: 10.1016/j.brainres.2014.01.047.", "ArticleIdList": ["10.1016/j.brainres.2014.01.047", "PMC4024464", "24502982"]}, {"Citation": "Li R., Robinson M., Ding X., Geetha T., Al-Nakkash L., Broderick T.L., Babu J.R. Genistein: A focus on several neurodegenerative diseases. J. Food Biochem. 2022;46:e14155. doi: 10.1111/jfbc.14155.", "ArticleIdList": ["10.1111/jfbc.14155", "35460092"]}, {"Citation": "Siddique Y.H., Naz F., Jyoti S., Ali F., Rahul Effect of Genistein on the Transgenic Drosophila Model of Parkinson\u2019s Disease. J. Diet. Suppl. 2019;16:550\u2013563. doi: 10.1080/19390211.2018.1472706.", "ArticleIdList": ["10.1080/19390211.2018.1472706", "29969325"]}, {"Citation": "Liu L., Chen W., Xie J., Wong M. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson\u2019s disease. Neurosci. Res. 2008;60:156\u2013161. doi: 10.1016/j.neures.2007.10.005.", "ArticleIdList": ["10.1016/j.neures.2007.10.005", "18054104"]}, {"Citation": "Khoddami A., Wilkes M.A., Roberts T.H. Techniques for Analysis of Plant Phenolic Compounds. Molecules. 2013;18:2328\u20132375. doi: 10.3390/molecules18022328.", "ArticleIdList": ["10.3390/molecules18022328", "PMC6270361", "23429347"]}, {"Citation": "Caruso G., Godos J., Privitera A., Lanza G., Castellano S., Chillemi A., Bruni O., Ferri R., Caraci F., Grosso G. Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer\u2019s Disease. Nutrients. 2022;14:819. doi: 10.3390/nu14040819.", "ArticleIdList": ["10.3390/nu14040819", "PMC8875888", "35215469"]}, {"Citation": "Shabani S., Rabiei Z., Amini-Khoei H. Exploring the multifaceted neuroprotective actions of gallic acid: A review. Int. J. Food Prop. 2020;23:736\u2013752. doi: 10.1080/10942912.2020.1753769.", "ArticleIdList": ["10.1080/10942912.2020.1753769"]}, {"Citation": "Chandrasekhar Y., Kumar G.P., Ramya E.M., Anilakumar K.R. Gallic Acid Protects 6-OHDA Induced Neurotoxicity by Attenuating Oxidative Stress in Human Dopaminergic Cell Line. Neurochem. Res. 2018;43:1150\u20131160. doi: 10.1007/s11064-018-2530-y.", "ArticleIdList": ["10.1007/s11064-018-2530-y", "29671234"]}, {"Citation": "Abdelsalam S.A., Renu K., Zahra H.A., Abdallah B.M., Ali E.M., Veeraraghavan V.P., Sivalingam K., Ronsard L., Ammar R.B., Vidya D.S., et al. Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update. Nutrients. 2023;15:1107. doi: 10.3390/nu15051107.", "ArticleIdList": ["10.3390/nu15051107", "PMC10005012", "36904106"]}, {"Citation": "Pathan A.S., Jain P.G., Kumawat V.S., Katolkar U.N., Surana S.J. Neuroprotective Effects of P-Coumaric Acid on Haloperidol-Induced Catalepsy Through Ameliorating Oxidative Stress and Brain Dopamine Level. J. Pharmacol. Pharmacother. 2022;13:364\u2013374. doi: 10.1177/0976500X221150837.", "ArticleIdList": ["10.1177/0976500X221150837"]}, {"Citation": "Dolrahman N., Mukkhaphrom W., Sutirek J., Thong-Asa W. Benefits of p-coumaric acid in mice with rotenone-induced neurodegeneration. Metab. Brain Dis. 2023;38:373\u2013382. doi: 10.1007/s11011-022-01113-2.", "ArticleIdList": ["10.1007/s11011-022-01113-2", "36308586"]}, {"Citation": "Guven M., Yuksel Y., Sehitoglu M.H., Tokmak M., Aras A.B., Akman T., Golge U.H., Goksel F., Karavelioglu E., Cosar M. The Effect of Coumaric Acid on Ischemia-Reperfusion Injury of Sciatic Nerve in Rats. Inflammation. 2015;38:2124\u20132132. doi: 10.1007/s10753-015-0195-0.", "ArticleIdList": ["10.1007/s10753-015-0195-0", "26049410"]}, {"Citation": "Pluta R., Miziak B., Czuczwar S.J. Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer\u2019s Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids. Molecules. 2023;28:5624. doi: 10.3390/molecules28155624.", "ArticleIdList": ["10.3390/molecules28155624", "PMC10420307", "37570596"]}, {"Citation": "Sharifi-Rad J., Quispe C., Castillo C.M.S., Caroca R., Lazo-V\u00e9lez M.A., Antonyak H., Polishchuk A., Lysiuk R., Oliinyk P., Masi L.D., et al. Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential. Oxid. Med. Cell. Longev. 2022;2022:3848084. doi: 10.1155/2022/3848084.", "ArticleIdList": ["10.1155/2022/3848084", "PMC8885183", "35237379"]}, {"Citation": "Ardah M.T., Bharathan G., Kitada T., Haque M.E. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson\u2019s Disease. Biomolecules. 2020;10:1519. doi: 10.3390/biom10111519.", "ArticleIdList": ["10.3390/biom10111519", "PMC7694688", "33172035"]}, {"Citation": "Sarkaki A., Farbood Y., Dolatshahi M., Mansouri S.M.T., Khodadadi A. Neuroprotective Effects of Ellagic Acid in a Rat Model of Parkinson\u2019s Disease. Acta Med. Iran. 2016;54:494\u2013502.", "ArticleIdList": ["27701719"]}, {"Citation": "Tian L., Wang X., Sun Y., Li C., Xing Y., Zhao H., Duan M., Zhou Z., Wang S. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int. J. Biochem. Cell Biol. 2008;40:409\u2013422. doi: 10.1016/j.biocel.2007.08.005.", "ArticleIdList": ["10.1016/j.biocel.2007.08.005", "17884684"]}, {"Citation": "Zhou J., Qu X., Li Z., Ji W., Liu Q., Ma Y., He J. Salvianolic Acid B Attenuates Toxin-Induced Neuronal Damage via Nrf2-Dependent Glial Cells-Mediated Protective Activity in Parkinson\u2019s Disease Models. PLoS ONE. 2014;9:e101668. doi: 10.1371/journal.pone.0101668.", "ArticleIdList": ["10.1371/journal.pone.0101668", "PMC4081637", "24991814"]}, {"Citation": "Zhao R., Liu X., Zhang L., Yang H., Zhang Q. Current Progress of Research on Neurodegenerative Diseases of Salvianolic Acid B. Oxid. Med. Cell. Longev. 2019;2019:3281260. doi: 10.1155/2019/3281260.", "ArticleIdList": ["10.1155/2019/3281260", "PMC6612994", "31341529"]}, {"Citation": "G\u00fczelad O., \u00d6zkan A., Parlak H., Sinen O., Af\u015far E., \u00d6\u011f\u00fct E., Y\u0131ld\u0131r\u0131m F.B., B\u00fclb\u00fcl M., A\u011far A., Aslan M. Protective mechanism of Syringic acid in an experimental model of Parkinson\u2019s disease. Metab. Brain Dis. 2021;36:1003\u20131014. doi: 10.1007/s11011-021-00704-9.", "ArticleIdList": ["10.1007/s11011-021-00704-9", "33666819"]}, {"Citation": "Ogut E., Armagan K., G\u00fcl Z. The role of syringic acid as a neuroprotective agent for neurodegenerative disorders and future expectations. Metab. Brain Dis. 2022;37:859\u2013880. doi: 10.1007/s11011-022-00960-3.", "ArticleIdList": ["10.1007/s11011-022-00960-3", "35334041"]}, {"Citation": "Cheemanapalli S., Mopuri R., Golla R., Anuradha C.M., Chitta S.K. Syringic acid (SA)\u2014A Review of Its Occurrence, Biosynthesis, Pharmacological and Industrial Importance. Biomed. Pharmacother. 2018;108:547\u2013557. doi: 10.1016/j.biopha.2018.09.069.", "ArticleIdList": ["10.1016/j.biopha.2018.09.069", "30243088"]}, {"Citation": "Presti-Silva S.M., Herlinger A.L., Martins-Silva C., Pires R.G.W. Biochemical and behavioral effects of rosmarinic acid treatment in an animal model of Parkinson\u2019s disease induced by MPTP. Behav. Brain Res. 2023;440:114257. doi: 10.1016/j.bbr.2022.114257.", "ArticleIdList": ["10.1016/j.bbr.2022.114257", "36526017"]}, {"Citation": "Lv R., Du L., Liu X., Zhou F., Zhang Z., Zhang L. Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1/TLR4/NF-\u03baB signaling pathway in a mouse model of Parkinson\u2019s disease. Life Sci. 2019;223:158\u2013165. doi: 10.1016/j.lfs.2019.03.030.", "ArticleIdList": ["10.1016/j.lfs.2019.03.030", "30880023"]}, {"Citation": "Cai G., Lin F., Wu D., Lin C., Chen H., Wei Y., Weng H., Chen Z., Wu M., Huang E., et al. Rosmarinic Acid Inhibits Mitochondrial Damage by Alleviating Unfolded Protein Response. Front. Pharmacol. 2022;13:859978. doi: 10.3389/fphar.2022.859978.", "ArticleIdList": ["10.3389/fphar.2022.859978", "PMC9149082", "35652041"]}, {"Citation": "War A.R., Paulraj M.G., Ahmad T., Buhroo A.A., Hussain B., Ignacimuthu S., Sharma H.C. Mechanisms of plant defense against insect herbivores. Plant Signal. Behav. 2012;7:1306\u20131320. doi: 10.4161/psb.21663.", "ArticleIdList": ["10.4161/psb.21663", "PMC3493419", "22895106"]}, {"Citation": "Dehghanian Z., Habibi K., Dehghanian M., Aliyar S., Asgari Lajayer B., Astatkie T., Minkina T., Keswani C. Reinforcing the bulwark: Unravelling the efficient applications of plant phenolics and tannins against environmental stresses. Heliyon. 2022;8:e09094. doi: 10.1016/j.heliyon.2022.e09094.", "ArticleIdList": ["10.1016/j.heliyon.2022.e09094", "PMC8927939", "35309390"]}, {"Citation": "Giuliano C., Cerri S., Blandini F. Potential therapeutic effects of polyphenols in Parkinson\u2019s disease: In vivo and in vitro pre-clinical studies. Neural Regen. Res. 2021;16:234\u2013241. doi: 10.4103/1673-5374.290879.", "ArticleIdList": ["10.4103/1673-5374.290879", "PMC7896204", "32859769"]}, {"Citation": "Huh E., Choi J.G., Choi Y., Ju I.G., Noh D., Shin D., Kim D.H., Park H., Oh M.S. 6-Shogaol, an Active Ingredient of Ginger, Improves Intestinal and Brain Abnormalities in Proteus Mirabilis-Induced Parkinson\u2019s Disease Mouse Model. Biomol. Ther. 2023;31:417\u2013424. doi: 10.4062/biomolther.2023.098.", "ArticleIdList": ["10.4062/biomolther.2023.098", "PMC10315336", "37337830"]}, {"Citation": "Ha S.K., Moon E., Ju M.S., Kim D.H., Ryu J.H., Oh M.S., Kim S.Y. 6-Shogaol, a ginger product, modulates neuroinflammation: A new approach to neuroprotection. Neuropharmacology. 2012;63:211\u2013223. doi: 10.1016/j.neuropharm.2012.03.016.", "ArticleIdList": ["10.1016/j.neuropharm.2012.03.016", "22465818"]}, {"Citation": "Gwon M.G., Gu H., Leem J., Park K.K. Protective Effects of 6-Shogaol, an Active Compound of Ginger, in a Murine Model of Cisplatin-Induced Acute Kidney Injury. Molecules. 2021;26:5931. doi: 10.3390/molecules26195931.", "ArticleIdList": ["10.3390/molecules26195931", "PMC8512008", "34641472"]}, {"Citation": "Sandoval-Avila S., Diaz N.F., G\u00f3mez-Pinedo U., Canales-Aguirre A.A., Guti\u00e9rrez-Mercado Y.K., Padilla-Camberos E., Marquez-Aguirre A.L., D\u00edaz-Mart\u00ednez N.E. Neuroprotective effects of phytochemicals on dopaminergic neuron cultures. Neurologia. 2019;34:114\u2013124. doi: 10.1016/j.nrl.2016.04.018.", "ArticleIdList": ["10.1016/j.nrl.2016.04.018", "27342389"]}, {"Citation": "Angeline M.S., Sarkar A., Anand K., Ambasta R.K., Kumar P. Sesamol and naringenin reverse the effect of rotenone-induced PD rat model. Neuroscience. 2013;254:379\u2013394. doi: 10.1016/j.neuroscience.2013.09.029.", "ArticleIdList": ["10.1016/j.neuroscience.2013.09.029", "24070629"]}, {"Citation": "Singh N., Vishwas S., Kaur A., Kaur H., Kakoty V., Khursheed R., Chaitanya M.V.N.L., Babu M.R., Awasthi A., Corrie L., et al. Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases. Biomed. Pharmacother. 2023;167:115512. doi: 10.1016/j.biopha.2023.115512.", "ArticleIdList": ["10.1016/j.biopha.2023.115512", "37725878"]}, {"Citation": "Bosebabu B., Cheruku S.P., Chamallamudi M.R., Nampoothiri M., Shenoy R.R., Nandakumar K., Parihar V.K., Kumar N. An Appraisal of Current Pharmacological Perspectives of Sesamol: A Review. Mini Rev. Med. Chem. 2020;20:988\u20131000. doi: 10.2174/1389557520666200313120419.", "ArticleIdList": ["10.2174/1389557520666200313120419", "32167426"]}, {"Citation": "Shah A., Lobo R., Krishnadas N., Surubhotla R. Sesamol and Health\u2014A Comprehensive Review. Indian J. Pharm. Educ. 2019;53:S28\u2013S42. doi: 10.5530/ijper.53.2s.46.", "ArticleIdList": ["10.5530/ijper.53.2s.46"]}, {"Citation": "Teka T., Zhang L., Ge X., Li Y., Han L., Yan X. Stilbenes: Source plants, chemistry, biosynthesis, pharmacology, application and problems related to their clinical Application\u2014A comprehensive review. Phytochemistry. 2022;197:113128. doi: 10.1016/j.phytochem.2022.113128.", "ArticleIdList": ["10.1016/j.phytochem.2022.113128", "35183567"]}, {"Citation": "El Khawand T., Courtois A., Valls J., Richard T., Krisa S. A review of dietary stilbenes: Sources and bioavailability. Phytochem. Rev. 2018;17:1007\u20131029. doi: 10.1007/s11101-018-9578-9.", "ArticleIdList": ["10.1007/s11101-018-9578-9"]}, {"Citation": "Huang K.S., Lin M. Oligostilbenes from the roots of Vitis amurensis. J. Asian Nat. Prod. Res. 1999;2:21\u201328. doi: 10.1080/10286029908039886.", "ArticleIdList": ["10.1080/10286029908039886", "11261202"]}, {"Citation": "Ryu H., Oh W.K., Jang I., Park J. Amurensin G induces autophagy and attenuates cellular toxicities in a rotenone model of Parkinson\u2019s disease. Biochem. Biophys. Res. Commun. 2013;433:121\u2013126. doi: 10.1016/j.bbrc.2013.02.053.", "ArticleIdList": ["10.1016/j.bbrc.2013.02.053", "23485458"]}, {"Citation": "Zhang L., Dong M., Deng J., Zhang C., Liu M. Resveratrol exhibits neuroprotection against paraquat-induced PC12 cells via heme oxygenase 1 upregulation by decreasing MiR-136-5p expression. Bioengineered. 2022;13:7065\u20137081. doi: 10.1080/21655979.2022.2045764.", "ArticleIdList": ["10.1080/21655979.2022.2045764", "PMC8974050", "35236239"]}, {"Citation": "Santos M.G.D., Schimith L.E., Andr\u00e9-Miral C., Muccillo-Baisch A.L., Arbo B.D., Hort M.A. Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson\u2019s Disease: A Systematic Review. Neurotox. Res. 2022;40:319\u2013345. doi: 10.1007/s12640-021-00450-x.", "ArticleIdList": ["10.1007/s12640-021-00450-x", "35013904"]}, {"Citation": "Nebrisi E.E. Neuroprotective Activities of Curcumin in Parkinson\u2019s Disease: A Review of the Literature. Int. J. Mol. Sci. 2021;22:11248. doi: 10.3390/ijms222011248.", "ArticleIdList": ["10.3390/ijms222011248", "PMC8537234", "34681908"]}, {"Citation": "Patel A., Olang C.A., Lewis G., Mandalaneni K., Anand N., Gorantla V.R. An Overview of Parkinson\u2019s Disease: Curcumin as a Possible Alternative Treatment. Cureus. 2022;14:e25032. doi: 10.7759/cureus.25032.", "ArticleIdList": ["10.7759/cureus.25032", "PMC9199586", "35719816"]}, {"Citation": "Jin T., Zhang Y., Botchway B.O.A., Zhang J., Fan R., Zhang Y., Liu X. Curcumin can improve Parkinson\u2019s disease via activating BDNF/PI3k/Akt signaling pathways. Food Chem. Toxicol. 2022;164:113091. doi: 10.1016/j.fct.2022.113091.", "ArticleIdList": ["10.1016/j.fct.2022.113091", "35526734"]}, {"Citation": "Mogharbel B.F., Cardoso M.A., Irioda A.C., Stricker P.E.F., Slompo R.C., Appel J.M., Oliveira N.B., Perussolo M.C., Sa\u00e7aki C.S., Rosa N.N., et al. Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson\u2019s Disease. Molecules. 2022;27:2811. doi: 10.3390/molecules27092811.", "ArticleIdList": ["10.3390/molecules27092811", "PMC9101601", "35566173"]}, {"Citation": "Fikry H., Saleh L.A., Gawad S.A. Neuroprotective effects of curcumin on the cerebellum in a rotenone- induced Parkinson\u2019s Disease Model. CNS Neurosci. Ther. 2022;28:732\u2013748. doi: 10.1111/cns.13805.", "ArticleIdList": ["10.1111/cns.13805", "PMC8981438", "35068069"]}, {"Citation": "Xu Y., Wei H., Gao J. Natural Terpenoids as Neuroinflammatory Inhibitors in LPS-stimulated BV-2 Microglia. Mini Rev. Med. Chem. 2021;21:520\u2013534. doi: 10.2174/1389557519666190611124539.", "ArticleIdList": ["10.2174/1389557519666190611124539", "31198113"]}, {"Citation": "Del Prado-Audelo M.L., Cort\u00e9s H., Caballero-Flor\u00e1n I.H., Gonz\u00e1lez-Torres M., Escutia-Guadarrama L., Bernal-Ch\u00e1vez S.A., Giraldo-Gomez D.M., Maga\u00f1a J.J., Leyva-G\u00f3mez G. Therapeutic Applications of Terpenes on Inflammatory Diseases. Front. Pharmacol. 2021;12:704197. doi: 10.3389/fphar.2021.704197.", "ArticleIdList": ["10.3389/fphar.2021.704197", "PMC8414653", "34483907"]}, {"Citation": "Gonz\u00e1lez-Burgos E., G\u00f3mez-Serranillos M.P. Terpene compounds in nature: A review of their potential antioxidant activity. Curr. Med. Chem. 2012;19:5319\u20135341. doi: 10.2174/092986712803833335.", "ArticleIdList": ["10.2174/092986712803833335", "22963623"]}, {"Citation": "Masyita A., Sari R.M., Astuti A.D., Yasir B., Rumata N.R., Emran T.B., Nainu F., Simal-Gandaraf J. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem. X. 2022;13:100217. doi: 10.1016/j.fochx.2022.100217.", "ArticleIdList": ["10.1016/j.fochx.2022.100217", "PMC9039924", "35498985"]}, {"Citation": "Wu C., Tsai C., Chang S., Lin C., Huang L., Tsai C. Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson\u2019s disease: Involvement of antioxidative enzymes induction. Chem. Biol. Interact. 2015;225:40\u201346. doi: 10.1016/j.cbi.2014.11.011.", "ArticleIdList": ["10.1016/j.cbi.2014.11.011", "25446857"]}, {"Citation": "Lai C.Y., Lin C.Y., Wu C.R., Tsai C.H., Tsai C.W. Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells. Front. Pharmacol. 2021;12:703894. doi: 10.3389/fphar.2021.703894.", "ArticleIdList": ["10.3389/fphar.2021.703894", "PMC8381221", "34434108"]}, {"Citation": "Mirza F.J., Zahid S., Holsinger R.M.D. Neuroprotective Effects of Carnosic Acid: Insight into Its Mechanisms of Action. Molecules. 2023;28:2306. doi: 10.3390/molecules28052306.", "ArticleIdList": ["10.3390/molecules28052306", "PMC10005014", "36903551"]}, {"Citation": "Jiang Y., Liu Y., Ding C., Feng X. Protective Effect of Ginkgolide B on Dopaminergic Neurons and Expression of Neuroinflammatory Factors in 6-OHDA-Induced Parkinson\u2019s Disease Mice. J. Biomater. Tissue Eng. 2020;10:1312\u20131317. doi: 10.1166/jbt.2020.2425.", "ArticleIdList": ["10.1166/jbt.2020.2425"]}, {"Citation": "Yin J., Miao Q., Wang Q., Huang J., Xiao B., Ma C. The protective effect of Ginkgolide B on MPTP-induced Parkinson mice. J. Neurol. Sci. 2021;429:119481. doi: 10.1016/j.jns.2021.119481.", "ArticleIdList": ["10.1016/j.jns.2021.119481"]}, {"Citation": "Zhao Y., Xiong S., Liu P., Liu W., Wang Q., Liu Y., Tan H., Chen X., Shi X., Wang Q., et al. Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson\u2019s Disease. Int. J. Nanomed. 2020;15:10453\u201310467. doi: 10.2147/IJN.S272831.", "ArticleIdList": ["10.2147/IJN.S272831", "PMC7769078", "33380795"]}, {"Citation": "Nabavi S.M., Habtemariam S., Daglia M., Braidy N., Loizzo M.R., Tundis R., Nabavi S.F. Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature. Curr. Top. Med. Chem. 2015;15:2222\u20132232. doi: 10.2174/1568026615666150610142647.", "ArticleIdList": ["10.2174/1568026615666150610142647", "26059355"]}, {"Citation": "Gachowska M., Szlasa W., Saczko J., Kulbacka J. Neuroregulatory role of ginkgolides. Mol. Biol. Rep. 2021;48:5689\u20135697. doi: 10.1007/s11033-021-06535-2.", "ArticleIdList": ["10.1007/s11033-021-06535-2", "PMC8338821", "34245409"]}, {"Citation": "Xia S., Fang D. Pharmacological action and mechanisms of ginkgolide B. Chin. Med. J. 2007;120:922\u2013928. doi: 10.1097/00029330-200705020-00013.", "ArticleIdList": ["10.1097/00029330-200705020-00013", "17543184"]}, {"Citation": "Shi J., Li J., Xu Z., Chen L., Luo R., Zhang C., Gao F., Zhang J., Fu C. Celastrol: A Review of Useful Strategies Overcoming its Limitation in Anticancer Application. Front. Pharmacol. 2020;11:558741. doi: 10.3389/fphar.2020.558741.", "ArticleIdList": ["10.3389/fphar.2020.558741", "PMC7751759", "33364939"]}, {"Citation": "Lin M., Lin C.C., Chen Y., Yang H., Hung S. Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson\u2019s Disease through Activating Mitophagy. Antioxidants. 2019;9:37. doi: 10.3390/antiox9010037.", "ArticleIdList": ["10.3390/antiox9010037", "PMC7022523", "31906147"]}, {"Citation": "Cui Y., Jiang X., Feng J. The therapeutic potential of triptolide and celastrol in neurological diseases. Front. Pharmacol. 2022;13:1024955. doi: 10.3389/fphar.2022.1024955.", "ArticleIdList": ["10.3389/fphar.2022.1024955", "PMC9626530", "36339550"]}, {"Citation": "Bai X., Fu R., Zhang S., Yue S., Chen Y., Xu D., Tang Y. Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases. Biomed. Pharmacother. 2021;139:111551. doi: 10.1016/j.biopha.2021.111551.", "ArticleIdList": ["10.1016/j.biopha.2021.111551", "33865016"]}, {"Citation": "Mosquera M.E.G., Jim\u00e9nez G., Tabernero V., Vinueza-Vaca J., Garc\u00eda-Estrada C., Kosalkov\u00e1 K., Sola-Landa A., Monje B., Acosta C., Alonso R., et al. Terpenes and Terpenoids: Building Blocks to Produce Biopolymers. Sustain. Chem. 2021;2:467\u2013492. doi: 10.3390/suschem2030026.", "ArticleIdList": ["10.3390/suschem2030026"]}, {"Citation": "Souza M.T.S., Almeida J.R.G.S., Araujo A.A.S., Duarte M.C., Gelain D.P., Moreira J.C.F., Santos M.R.V., Quintans-J\u00fanior L.J. Structure\u2013activity relationship of terpenes with anti-inflammatory profile- a systematic review. Basic Clin. Pharmacol. Toxicol. 2014;115:244\u2013256. doi: 10.1111/bcpt.12221.", "ArticleIdList": ["10.1111/bcpt.12221", "25275147"]}, {"Citation": "Zhang W., Song J., Yan R., Li L., Xiao Z., Zhou W., Wang Z., Xiao W., Du G. Diterpene ginkgolides protect against cerebral ischemia/reperfusion damage in rats by activating Nrf2 and CREB through PI3K/Akt signaling. Acta Pharmacol. Sin. 2018;39:1259\u20131272. doi: 10.1038/aps.2017.149.", "ArticleIdList": ["10.1038/aps.2017.149", "PMC6289361", "29542683"]}, {"Citation": "Moratilla-Rivera I., S\u00e1nchez M., Vald\u00e9s-Gonz\u00e1lez J.A., G\u00f3mez-Serranillos M.P. Natural Products as Modulators of Nrf2 Signaling Pathway in Neuroprotection. Int. J. Mol. Sci. 2023;24:3748. doi: 10.3390/ijms24043748.", "ArticleIdList": ["10.3390/ijms24043748", "PMC9967135", "36835155"]}, {"Citation": "Wang L., Lei Q., Zhao S., Xu W.J., Dong W., Ran J.H., Shi Q.H., Fu J.F. Ginkgolide B Maintains Calcium Homeostasis in Hypoxic Hippocampal Neurons by Inhibiting Calcium Influx and Intracellular Calcium Release. Front. Cell. Neurosci. 2021;14:627846. doi: 10.3389/fncel.2020.627846.", "ArticleIdList": ["10.3389/fncel.2020.627846", "PMC7928385", "33679323"]}, {"Citation": "Akkol E.K., \u00c7ankaya I.T., Karatoprak G.S., Carpar E., Sobarzo-S\u00e1nchez E., Capasso R. Natural Compounds as Medical Strategies in the Prevention and Treatment of Psychiatric Disorders Seen in Neurological Diseases. Front. Pharmacol. 2021;12:669638. doi: 10.3389/fphar.2021.669638.", "ArticleIdList": ["10.3389/fphar.2021.669638", "PMC8155682", "34054540"]}, {"Citation": "Bhambhani S., Kondhare K.R., Giri A.P. Diversity in Chemical Structures and Biological Properties of Plant Alkaloids. Molecules. 2021;26:3374. doi: 10.3390/molecules26113374.", "ArticleIdList": ["10.3390/molecules26113374", "PMC8199754", "34204857"]}, {"Citation": "Omar F., Tareq A.M., Alqahtani A.M., Dhama K., Sayeed M.A., Emran T.B., Simal-Gandara J. Plant-Based Indole Alkaloids: A Comprehensive Overview from a Pharmacological Perspective. Molecules. 2021;26:2297. doi: 10.3390/molecules26082297.", "ArticleIdList": ["10.3390/molecules26082297", "PMC8071433", "33921093"]}, {"Citation": "Hussain G., Rasul A., Anwar H., Aziz N., Razzaq A., Wei W., Ali M., Li J., Li X. Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders. Int. J. Biol. Sci. 2018;14:341\u2013357. doi: 10.7150/ijbs.23247.", "ArticleIdList": ["10.7150/ijbs.23247", "PMC5859479", "29559851"]}, {"Citation": "Kempste P., Ma A. Parkinson\u2019s disease, dopaminergic drugs and the plant world. Front. Pharmacol. 2022;13:970714. doi: 10.3389/fphar.2022.970714.", "ArticleIdList": ["10.3389/fphar.2022.970714", "PMC9483127", "36133818"]}, {"Citation": "Aryal B., Raut B.K., Bhattarai S., Bhandari S., Tandan P., Gyawali K., Sharma K., Ranabhat D., Thapa R., Aryal D., et al. Potential Therapeutic Applications of Plant-Derived Alkaloids against Inflammatory and Neurodegenerative Diseases. Evid.-Based Complement. Altern. Med. 2022;2022:7299778. doi: 10.1155/2022/7299778.", "ArticleIdList": ["10.1155/2022/7299778", "PMC8926539", "35310033"]}, {"Citation": "Kong Y.R., Tay K.C., Su Y.X., Wong C.K., Tan W.N., Khaw K.Y. Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases. Molecules. 2021;26:728. doi: 10.3390/molecules26030728.", "ArticleIdList": ["10.3390/molecules26030728", "PMC7866829", "33573300"]}, {"Citation": "Kabuto H., Yamanushi T.T. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl) phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson\u2019s disease mouse model. Neurochem. Res. 2011;36:2244\u20132249. doi: 10.1007/s11064-011-0548-5.", "ArticleIdList": ["10.1007/s11064-011-0548-5", "21769642"]}, {"Citation": "Kabuto H., Nishizawa M., Tada M., Higashio C., Shishibori T., Kohno M. Zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] prevents 6-hydroxydopamine-induced dopamine depression in mouse striatum and increases superoxide scavenging activity in serum. Neurochem. Res. 2005;30:325\u2013332. doi: 10.1007/s11064-005-2606-3.", "ArticleIdList": ["10.1007/s11064-005-2606-3", "16018576"]}, {"Citation": "Saraiva A.A., Silva J.P.O.D., Sousa J.V.M., Brandim A.D. Molecular Docking of Zingerone and Gamma-Mangostin to Inhibit MAO-B and Catechol-O-Methyltransferase (COMT) in the Treatment of Parkinson\u2019s Disease. Res. Soc. Dev. 2022;11:e189111637853. doi: 10.33448/rsd-v11i16.37853.", "ArticleIdList": ["10.33448/rsd-v11i16.37853"]}, {"Citation": "Rashid S., Wali A.F., Rashid S.M., Alsaffar R.M., Ahmad A., Jan B.L., Paray B.A., Alqahtani S.M.A., Arafah A., Rehman M.U. Zingerone Targets Status Epilepticus by Blocking Hippocampal Neurodegeneration via Regulation of Redox Imbalance, Inflammation and Apoptosis. Pharmaceuticals. 2021;14:146. doi: 10.3390/ph14020146.", "ArticleIdList": ["10.3390/ph14020146", "PMC7918711", "33670383"]}, {"Citation": "Ahmad B., Rehman M.U., Amin I., Arif A., Rasool S., Bhat S.A., Afzal I., Hussain I., Bilal S., Mir M.R. A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone) Sci. World J. 2015;2015:816364. doi: 10.1155/2015/816364.", "ArticleIdList": ["10.1155/2015/816364", "PMC4461790", "26106644"]}, {"Citation": "Fu R., Wang Y., Chen C., Tsai R., Liu S., Chang W., Lin H., Lu C., Wei J., Wang Z., et al. Acetylcorynoline attenuates dopaminergic neuron degeneration and \u03b1-synuclein aggregation in animal models of Parkinson\u2019s disease. Neuropharmacology. 2014;82:108\u2013120. doi: 10.1016/j.neuropharm.2013.08.007.", "ArticleIdList": ["10.1016/j.neuropharm.2013.08.007", "23973292"]}, {"Citation": "Han N., Yang Z., Liu Z., Liu H., Yin J. Research Progress on Natural Benzophenanthridine Alkaloids and their Pharmacological Functions: A Review. Nat. Prod. Commun. 2016;11:1181\u20131188. doi: 10.1177/1934578X1601100838.", "ArticleIdList": ["10.1177/1934578X1601100838", "30725587"]}, {"Citation": "Charlton N.C., Mastyugin M., T\u00f6r\u00f6k B., T\u00f6r\u00f6k M. Structural Features of Small Molecule Antioxidants and Strategic Modifications to Improve Potential Bioactivity. Molecules. 2023;28:1057. doi: 10.3390/molecules28031057.", "ArticleIdList": ["10.3390/molecules28031057", "PMC9920158", "36770724"]}, {"Citation": "Zhang Y., Yang Y., Yang X. Blood-brain barrier permeability and neuroprotective effects of three main alkaloids from the fruits of Euodia rutaecarpa with MDCK-pHaMDR cell monolayer and PC12 cell line. Biomed. Pharmacother. 2018;98:82\u201387. doi: 10.1016/j.biopha.2017.12.017.", "ArticleIdList": ["10.1016/j.biopha.2017.12.017", "29245070"]}, {"Citation": "Li J., Wu Y., Dong S., Yu Y., Wu Y., Xiang B., Li Q. Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids. Molecules. 2023;28:4797. doi: 10.3390/molecules28124797.", "ArticleIdList": ["10.3390/molecules28124797", "PMC10302352", "37375352"]}, {"Citation": "Xiao X., Tong Z., Zhang Y., Zhou H., Luo M., Hu T., Hu P., Kong L., Liu Z., Yu C., et al. Novel Prenylated Indole Alkaloids with Neuroprotection on SH-SY5Y Cells against Oxidative Stress Targeting Keap1\u2013Nrf2. Mar. Drugs. 2022;20:191. doi: 10.3390/md20030191.", "ArticleIdList": ["10.3390/md20030191", "PMC8952805", "35323490"]}, {"Citation": "Kongkiatpaiboon S., Duangdee N., Prateeptongkum S., Chaijaroenkul W. Acetylcholinesterase Inhibitory Activity of Alkaloids Isolated from Stephania venosa. Nat. Prod. Commun. 2016;11:1805\u20131806. doi: 10.1177/1934578X1601101208.", "ArticleIdList": ["10.1177/1934578X1601101208", "30508338"]}, {"Citation": "Nishal S., Phaugat P., Bazaad J., Dhaka R., Khatkar S., Khatkar A., Khayatkashani M., Alizadeh P., Haghighi S.M., Mehri M., et al. A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer\u2019s Disease and Parkinson\u2019s Disease: Insight into Structure-Activity-Relationship. CNS Neurol. Disord. Drug Targets. 2023;22:1057\u20131069. doi: 10.2174/1871527321666220614110616.", "ArticleIdList": ["10.2174/1871527321666220614110616", "35702799"]}, {"Citation": "Bhusal C.K., Uti D.E., Mukherjee D., Alqahtani T., Alqahtani S., Bhattacharya A., Akash S. Unveiling Nature\u2019s potential: Promising natural compounds in Parkinson\u2019s disease management. Park. Relat. Disord. 2023;10:105799. doi: 10.1016/j.parkreldis.2023.105799.", "ArticleIdList": ["10.1016/j.parkreldis.2023.105799", "37633805"]}, {"Citation": "Baburaj R., Kuntal D.A. Neuroprotective role of a protoberberine alkaloid against aluminium-induced neuroinflammation and excitotoxicity. Not. Sci. Biol. 2023;15:11488. doi: 10.55779/nsb15211488.", "ArticleIdList": ["10.55779/nsb15211488"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "9", "Day": "11"}, {"Year": "2023", "Month": "11", "Day": "6"}, {"Year": "2023", "Month": "11", "Day": "9"}, {"Year": "2023", "Month": "11", "Day": "27", "Hour": "12", "Minute": "43"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "12", "Minute": "47"}, {"Year": "2023", "Month": "11", "Day": "25", "Hour": "1", "Minute": "27"}, {"Year": "2023", "Month": "11", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["38005310", "PMC10673433", "10.3390/molecules28227588", "molecules28227588"]}}], "PubmedBookArticle": []}